A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People

Clinical trial NCT05227196 · COMPLETED

Trial details

NCT number: NCT05227196
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Type 2 Diabetes

Start date: 2022-02-04
Primary completion: 2023-06-28
Enrollment: 546

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.